These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24204143)

  • 1. 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen.
    Yang L; Choi SK; Shin HJ; Han HK
    Int J Nanomedicine; 2013; 8():4147-55. PubMed ID: 24204143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro/in vivo characterization of tranilast-AMP clay complex for improving drug dissolution and bioavailability.
    Yang L; Shao Y; Han HK
    Arch Pharm Res; 2014 Dec; 37(12):1554-9. PubMed ID: 25119994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
    Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
    Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex.
    Yang L; Shao Y; Han HK
    Int J Pharm; 2014 Aug; 471(1-2):258-63. PubMed ID: 24834880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
    Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS
    Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin.
    Uchiyama H; Tozuka Y; Imono M; Takeuchi H
    Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
    Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
    Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier.
    Oh DH; Kang JH; Kim DW; Lee BJ; Kim JO; Yong CS; Choi HG
    Int J Pharm; 2011 Nov; 420(2):412-8. PubMed ID: 21944892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
    Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
    Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
    Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
    Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-independent instantaneous release of flurbiprofen: a study of the preparation of complexes, their characterization and in vitro/in vivo evaluation.
    Wang HB; Yang FF; Gai XM; Cheng BC; Li JY; Pan H; Yang XG; Pan WS
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1460-1471. PubMed ID: 28402143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.
    Yang L; Shao Y; Han HK
    Int J Nanomedicine; 2016; 11():1067-76. PubMed ID: 27042061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of malachite green by adsorption and precipitation using aminopropyl functionalized magnesium phyllosilicate.
    Lee YC; Kim EJ; Yang JW; Shin HJ
    J Hazard Mater; 2011 Aug; 192(1):62-70. PubMed ID: 21616589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.
    Lee SH; Song JG; Han HK
    J Control Release; 2019 Oct; 311-312():74-84. PubMed ID: 31487499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery.
    Park KM; Kim CK
    Int J Pharm; 1999 Apr; 181(2):173-9. PubMed ID: 10370213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.